सभी अध्ययन
भर्तीचिकित्सीय पुष्टि (चरण III)हस्तक्षेपात्मक

H8H-MC-LAHV: Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1

The PIONEER-PEDS1 study is a research project focusing on children and teenagers who experience migraine headaches. Researchers are testing a potential new medicine called lasmiditan to see how effective it is at stopping migraine pain once it starts. They are comparing different strengths of lasmiditan against a placebo, which is a tablet that looks the same but contains no active medicine. This helps them understand if lasmiditan truly works better than nothing. This study is in its final phase (Phase III), meaning it's a large and important step to confirm if the treatment is safe and effective before it can be considered for wider use. Participants will be monitored closely to see if the medicine can make them pain-free.

एक नजर में

स्थिति
भर्ती
चरण
चिकित्सीय पुष्टि (चरण III)
प्रायोजक
Eli Lilly & Co.
नामांकन लक्ष्य
205
प्रारंभ
22 Mar 2024

यह अध्ययन किस बारे में है?

This research study, called PIONEER-PEDS1, is looking for better ways to treat migraine headaches in children and teenagers. Migraines are severe headaches that can cause throbbing pain, sickness, and sensitivity to light and sound. Finding quick and effective relief is very important for young people who suffer from them.

The study is testing a specific medicine called lasmiditan. It’s designed to help stop a migraine attack once it has started. Researchers want to find out if lasmiditan can make young people completely pain-free during a migraine, and how different doses compare. They are also comparing it to a 'placebo', which is a pill that looks identical but doesn’t contain any medicine. This helps the researchers know for sure if any improvements seen are due to the actual medicine or something else.

This kind of study is called a 'Phase III' study, which means it’s one of the final and most important steps before a new medicine can be considered for approval. It’s a large-scale study designed to confirm how well the medicine works and if it’s safe for the age group being studied.

मुख्य निष्कर्ष

  • The study is for children and teenagers with migraine headaches.
  • It's testing a new medicine called lasmiditan to stop migraine pain.
  • Participants will receive either lasmiditan or a dummy pill (placebo).
  • This is a large, final-stage study (Phase III).
  • Participation involves taking medication and keeping track of migraine symptoms.
  • आप किसी भी समय भाग लेना बंद कर सकते हैं।.

कौन पात्र हो सकता है?

This study is open to both boys and girls of all ages who suffer from migraine headaches. If you or your child gets migraines, this study might be an option to consider.

Before anyone can join, the study team will need to check some things to make sure it's safe and appropriate. This usually involves reviewing medical history and making sure the migraine condition fits the study's requirements.

It's important to remember that even if you meet the basic age and sex criteria, there might be other specific health conditions or medications that would prevent someone from joining. The study team will discuss all of these details with you.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. Do you or your child get migraine headaches?
  2. Are you a boy or a girl of any age?
  3. Are you able to attend study appointments as required?
  4. Are you willing to take a study medicine or a placebo?
  5. Are you willing to track your migraine symptoms carefully?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

If you or your child decides to take part in this study, you would first have a screening visit. During this visit, the study team would check if you meet all the requirements. If eligible, you would then be given either the study medicine (lasmiditan) or a dummy pill (placebo) to take when a migraine starts. You wouldn't know which one you're taking, which is common in these types of studies.

You would need to record information about your migraines and how you feel after taking the medication. There will be regular follow-up visits or phone calls to check on your progress and any side effects. The total duration of participation would be explained fully by the study team, but typically these studies involve several months of monitoring.

संभावित जोखिम और लाभ

Taking part in a study like this could offer potential benefits, such as access to a new migraine treatment before it's widely available and close medical monitoring. However, there are also potential risks, including side effects from the study medicine or the discomfort of study procedures. As with any medication, there's always a chance the treatment might not work for you, or you might receive the placebo. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

स्थान (7)

कुछ साइट स्थान अनुमानित हैं। हम इसे सुधार रहे हैं — कृपया यात्रा करने से पहले परीक्षण टीम से सत्यापित करें।.
  • —
    असत्यापित
    नीदरलैंड्स
  • —
    असत्यापित
    जर्मनी
  • —
    असत्यापित
    स्पेन
  • —
    असत्यापित
    बेल्जियम
  • —
    असत्यापित
    रोमानिया
  • —
    असत्यापित
    इटली
  • —
    असत्यापित
    फ्रांस

सामान्य प्रश्न

'प्लेसबो' क्या है?

A placebo is a pill or treatment that looks exactly like the study medicine but doesn't contain any active drug. It helps researchers compare the real medicine's effects.

क्या मुझे पता चलेगा कि मुझे असली दवा मिल रही है या प्लेसीबो?

No, this is a 'blinded' study. Neither you nor your doctor will know if you're taking the study medicine or the placebo. This helps make the study results fair.

What does 'Phase III' mean for a medicine?

Phase III is a late stage of research where a new medicine is tested on a large number of people to confirm its effectiveness and safety before it can be considered for approval.

मैं अध्ययन में कितने समय तक रहूँगा?

The exact duration for each participant will be explained by the study team, but typically these studies involve several months of participation and follow-up.

क्या मुझे अध्ययन में शामिल होने के लिए भुगतान करना होगा?

No, participation in clinical trials is generally free. The study will cover costs related to the research treatment and visits.

और अधिक जानने के लिए कैसे पता करें

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

भाग लेने में रुचि रखते हैं?

अपनी रुचि दर्ज करें

अपने विवरण साझा करें और अनुसंधान टीम के लिए "H8H-MC-LAHV: Pediatric Options for Migraine Relief: A Random…यदि आप पात्र हो सकते हैं तो आपसे संपर्क करेंगे। भाग लेने के लिए सहमति देने से पहले हमेशा अपने जीपी से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.